Neonatal extracorporeal membrane oxygenation: Neurodevelopmental outcome of survivors

Jan G. Hunter, Joseph B. Zwiscbenberger, Jatinder Bhatia

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Extracorporeal membrane oxygenation (ECMO) is a sophisticated life-saving treatment measure that uses modified heart-lung bypass to treat severe respiratory failure unresponsive to conventional medical management in a select group of term or near-term infants. A predicted mortality rate of 80% or more has been reversed to a survival rate of 80% or more. Significant biologic risk factors potentially affecting developmental outcome exist for these infants. Most ECMO survivors appear to be within normal limits on standard developmental testing, but major and minor sequelae have also been identified. Long-term developmental follow-up that includes evaluation of subtle neurologic, learning, and behavior parameters is advised.

Original languageEnglish (US)
Pages (from-to)63-76
Number of pages14
JournalInfants and Young Children
Volume4
Issue number4
StatePublished - Apr 1992

Fingerprint

Extracorporeal Membrane Oxygenation
Survivors
Biological Factors
Cardiopulmonary Bypass
Respiratory Insufficiency
Nervous System
Survival Rate
Learning
Mortality
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Cite this

Neonatal extracorporeal membrane oxygenation : Neurodevelopmental outcome of survivors. / Hunter, Jan G.; Zwiscbenberger, Joseph B.; Bhatia, Jatinder.

In: Infants and Young Children, Vol. 4, No. 4, 04.1992, p. 63-76.

Research output: Contribution to journalArticle

@article{59a5b6761a574bf6859874be7de97a26,
title = "Neonatal extracorporeal membrane oxygenation: Neurodevelopmental outcome of survivors",
abstract = "Extracorporeal membrane oxygenation (ECMO) is a sophisticated life-saving treatment measure that uses modified heart-lung bypass to treat severe respiratory failure unresponsive to conventional medical management in a select group of term or near-term infants. A predicted mortality rate of 80{\%} or more has been reversed to a survival rate of 80{\%} or more. Significant biologic risk factors potentially affecting developmental outcome exist for these infants. Most ECMO survivors appear to be within normal limits on standard developmental testing, but major and minor sequelae have also been identified. Long-term developmental follow-up that includes evaluation of subtle neurologic, learning, and behavior parameters is advised.",
author = "Hunter, {Jan G.} and Zwiscbenberger, {Joseph B.} and Jatinder Bhatia",
year = "1992",
month = "4",
language = "English (US)",
volume = "4",
pages = "63--76",
journal = "Infants and Young Children",
issn = "0896-3746",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Neonatal extracorporeal membrane oxygenation

T2 - Neurodevelopmental outcome of survivors

AU - Hunter, Jan G.

AU - Zwiscbenberger, Joseph B.

AU - Bhatia, Jatinder

PY - 1992/4

Y1 - 1992/4

N2 - Extracorporeal membrane oxygenation (ECMO) is a sophisticated life-saving treatment measure that uses modified heart-lung bypass to treat severe respiratory failure unresponsive to conventional medical management in a select group of term or near-term infants. A predicted mortality rate of 80% or more has been reversed to a survival rate of 80% or more. Significant biologic risk factors potentially affecting developmental outcome exist for these infants. Most ECMO survivors appear to be within normal limits on standard developmental testing, but major and minor sequelae have also been identified. Long-term developmental follow-up that includes evaluation of subtle neurologic, learning, and behavior parameters is advised.

AB - Extracorporeal membrane oxygenation (ECMO) is a sophisticated life-saving treatment measure that uses modified heart-lung bypass to treat severe respiratory failure unresponsive to conventional medical management in a select group of term or near-term infants. A predicted mortality rate of 80% or more has been reversed to a survival rate of 80% or more. Significant biologic risk factors potentially affecting developmental outcome exist for these infants. Most ECMO survivors appear to be within normal limits on standard developmental testing, but major and minor sequelae have also been identified. Long-term developmental follow-up that includes evaluation of subtle neurologic, learning, and behavior parameters is advised.

UR - http://www.scopus.com/inward/record.url?scp=0002477027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0002477027&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0002477027

VL - 4

SP - 63

EP - 76

JO - Infants and Young Children

JF - Infants and Young Children

SN - 0896-3746

IS - 4

ER -